Search

Author/Creator Brenner, Warren

1. A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Issue 1 (January 2022)

Authors:
Hewitt, Daniel Brock; Nissen, Nicholas; Hatoum, Hassan; Musher, Benjamin; Seng, John; Coveler, Andrew L.; Al-Rajabi, Raed; Yeo, Charles J.; Leiby, Benjamin; Banks, Joshua; Balducci, Lodovico; Vaccaro, Gina; LoConte, Noelle; George, Thomas J.; Brenner, Warren; Elquza, Emad; Vahanian, Nicholas; Ros...
Journal:
Annals of surgery
Issue:
Volume 275:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

Authors:
Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2022)
Page Start:
e403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search